-
Sangamo Therapeutics Inc (NASDAQ: SGMO) shares
jumped 52.2 percent to $6.62 after the company reported a strategic collaboration with Pfizer Inc. (NYSE: PFE) for Hemophilia A Phase 1/2 therapy program. The company also
posted a narrower-than-expected quarterly loss.
-
Real Industry Inc (NASDAQ: RELY) shares climbed
26.5 percent to $3.10 following Q1 results. Real Industry reported a Q1 loss of $0.43 per share on revenue of $337.1 million.
-
Walter Investment Management Corp (NYSE: WAC) shares
gained 22.3 percent to $1.81. On Wednesday, Walter Investment posted a narrower-than-expected quarterly loss.
-
LivePerson, Inc. (NASDAQ: LPSN) surged 18.3
percent to $9.40. LivePerson posted in-line quarterly earnings, while sales exceeded estimates.
-
Intrexon Corp (NYSE: XON) gained 16 percent to
$22.68. Intrexon reported a Q1 loss of $31.4 million on sales of $53.7 million.
-
Himax Technologies, Inc. (ADR) (NASDAQ: HIMX)
rose 14.5 percent to $7.84. Himax reported a Q1 profit of $1.4 million on revenue of $155.2 million.
-
Pegasystems Inc. (NASDAQ: PEGA) surged 12.5
percent to $53.50 after the company reported strong Q1 results.
-
Destination Maternity Corp (NASDAQ: DEST) gained
11.1 percent to $4.19.
-
Asure Software Inc (NASDAQ: ASUR) shares rose
10.8 percent to $14.34 as the company posted upbeat Q1 results and raised its forecast for fiscal 2017.
-
Kelly Services, Inc. (NASDAQ: KELYA) shares
jumped 5.2 percent to $23.07 after the company posted better-than-expected quarterly profit.
-
Neuralstem, Inc. (NYSE: CUR) shares gained 3.8
percent to $4.14 after surging 35.14 percent on Wednesday. Neuralstem reported a Q1 loss of $7.6 million.
-
Whole Foods Market, Inc. (NASDAQ: WFM) shares rose
3.7 percent to $37.58. Whole Foods reported in-line earnings for its second quarter and appointed Keith Manbeck as CFO. The
company also reported a new stock buyback plan and lifted its quarterly dividend by 29 percent. Wells Fargo upgraded Whole
Foods from Market Perform to Outperform.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.